SuperworthOrasure Technologies profit margin OSUR
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −43.7%
- Operating margin, 12 months
- −48.1%
- Net margin on a year earlier
- −6.9 pts
- Peer median
- 6.5%
Over the twelve months to Jun 30, 2026, Orasure Technologies kept −43.7% of its revenue as net profit, with an operating margin of −48.1% and a gross margin of 42.6%.
Five years earlier its net margin was 2.3%.
The median for 10 medical instruments and supplies stocks of a similar size is 6.5%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −59.8% | −62.6% | 41.9% |
| FY2024 | −10.5% | −15.2% | 42.7% |
| FY2023 | 13.2% | 8.1% | 42.3% |
| FY2022 | −4.4% | −5.7% | 38.3% |
| FY2021 | −9.8% | −4.3% | 50.3% |
| FY2020 | −8.7% | −3.0% | 59.3% |
| FY2019 | 10.8% | 12.0% | 61.2% |
| FY2018 | 11.2% | 15.6% | 62.5% |
| FY2017 | 18.5% | 24.1% | 59.2% |
| FY2016 | 15.4% | 15.8% | 68.7% |
| FY2015 | 6.8% | 6.7% | 67.1% |
| FY2014 | −4.3% | −4.5% | 62.6% |
| FY2013 | −11.3% | −12.3% | 59.2% |
| FY2012 | −17.2% | −18.5% | 63.3% |
| FY2011 | −10.8% | −11.5% | 63.2% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −43.7% | −6.9 pts | −48.1% | |
| Q1 FY26 | −66.4% | −46.7 pts | −68.6% | |
| Q4 FY25 | −59.8% | −49.3 pts | −62.6% | |
| Q3 FY25 | −47.9% | −53.0 pts | −51.1% | |
| Q2 FY25 | −36.8% | −46.7 pts | −39.1% | |
| Q1 FY25 | −19.8% | −27.3 pts | −24.1% | |
| Q4 FY24 | −10.5% | −23.7 pts | −15.2% | |
| Q3 FY24 | 5.1% | −5.8 pts | −5.3% | |
| Q2 FY24 | 9.9% | +0.8 pts | 1.8% | |
| Q1 FY24 | 7.5% | +1.2 pts | 0.4% | |
| Q4 FY23 | 13.2% | +17.7 pts | 8.1% | |
| Q3 FY23 | 10.9% | +24.1 pts | 9.6% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Orasure Technologies' size, closest first, today.
| Company | Profit margin |
|---|---|
| OSUROrasure Technologies | −43.7% |
| INFUInfuSystem | 6.0% |
| UTMDUtah Medical Products | 29.0% |
| EMBCEmbecta | 8.6% |
| PDEXPro DEX | 17.6% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| MOVMovado | 6.0% |
| KEQUKewaunee Scientific | 3.0% |
| IRMDIradimed | 26.7% |
| STAAStaar Surgical | 1.1% |
| Peer median | 6.5% |
Where Orasure Technologies ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Orasure Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.